| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocortisone | 37 | 2010 | 1838 | 1.830 |
Why?
|
| Pituitary-Adrenal System | 25 | 2010 | 553 | 1.830 |
Why?
|
| Depressive Disorder | 34 | 2012 | 3715 | 1.450 |
Why?
|
| Hypothalamo-Hypophyseal System | 16 | 2010 | 702 | 1.440 |
Why?
|
| Antidepressive Agents, Second-Generation | 8 | 2013 | 490 | 1.350 |
Why?
|
| Sleep, REM | 19 | 2013 | 593 | 1.200 |
Why?
|
| Citalopram | 4 | 2013 | 402 | 0.990 |
Why?
|
| Adrenocorticotropic Hormone | 21 | 2005 | 618 | 0.980 |
Why?
|
| Prolactin | 25 | 2005 | 628 | 0.970 |
Why?
|
| Corticosterone | 28 | 2006 | 301 | 0.960 |
Why?
|
| Scopolamine | 7 | 2004 | 92 | 0.830 |
Why?
|
| Depressive Disorder, Major | 11 | 2013 | 4810 | 0.810 |
Why?
|
| Dexamethasone | 22 | 2024 | 1962 | 0.800 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 6 | 2003 | 69 | 0.710 |
Why?
|
| Bupropion | 4 | 2013 | 303 | 0.680 |
Why?
|
| Life Change Events | 4 | 2010 | 956 | 0.670 |
Why?
|
| Nicotine | 7 | 2006 | 680 | 0.640 |
Why?
|
| Desipramine | 6 | 2008 | 182 | 0.620 |
Why?
|
| Phencyclidine | 9 | 2005 | 59 | 0.600 |
Why?
|
| Antidepressive Agents | 7 | 2012 | 2903 | 0.490 |
Why?
|
| Hallucinogens | 5 | 2003 | 212 | 0.450 |
Why?
|
| Stress, Psychological | 8 | 2011 | 4526 | 0.450 |
Why?
|
| Prenatal Exposure Delayed Effects | 16 | 2006 | 2537 | 0.440 |
Why?
|
| Immobilization | 2 | 2004 | 227 | 0.420 |
Why?
|
| Massage | 1 | 2012 | 84 | 0.400 |
Why?
|
| Antidepressive Agents, Tricyclic | 4 | 2008 | 427 | 0.400 |
Why?
|
| Sleep | 15 | 2013 | 4814 | 0.400 |
Why?
|
| Muscarinic Antagonists | 3 | 2004 | 135 | 0.380 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 326 | 0.370 |
Why?
|
| Rats | 49 | 2008 | 23717 | 0.350 |
Why?
|
| Sepsis | 5 | 2023 | 2604 | 0.350 |
Why?
|
| Social Support | 2 | 2011 | 2191 | 0.350 |
Why?
|
| Nicotinic Agonists | 2 | 2006 | 265 | 0.340 |
Why?
|
| Electroencephalography | 12 | 2009 | 6282 | 0.340 |
Why?
|
| Social Environment | 3 | 2010 | 1012 | 0.330 |
Why?
|
| Cross Infection | 4 | 2024 | 1427 | 0.330 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2023 | 279 | 0.320 |
Why?
|
| Serotonin Agents | 2 | 2000 | 29 | 0.320 |
Why?
|
| Saliva | 9 | 2009 | 852 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2008 | 8108 | 0.310 |
Why?
|
| Behavior, Animal | 5 | 2008 | 1865 | 0.310 |
Why?
|
| Fatigue Syndrome, Chronic | 2 | 2001 | 217 | 0.310 |
Why?
|
| Circadian Rhythm | 22 | 2012 | 2590 | 0.300 |
Why?
|
| Thyrotropin-Releasing Hormone | 6 | 1993 | 139 | 0.300 |
Why?
|
| Hypothalamic Diseases | 1 | 2009 | 132 | 0.290 |
Why?
|
| Radioimmunoassay | 11 | 2008 | 861 | 0.290 |
Why?
|
| Haloperidol | 8 | 1992 | 394 | 0.290 |
Why?
|
| Mecamylamine | 2 | 2006 | 27 | 0.290 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2001 | 186 | 0.290 |
Why?
|
| Dextromethorphan | 3 | 2004 | 37 | 0.290 |
Why?
|
| Receptors, Opioid | 6 | 1989 | 145 | 0.280 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 962 | 0.280 |
Why?
|
| Nicotinic Antagonists | 2 | 2006 | 94 | 0.270 |
Why?
|
| Urinary Tract Infections | 2 | 2024 | 804 | 0.270 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2023 | 584 | 0.270 |
Why?
|
| Mixed Function Oxygenases | 3 | 2006 | 265 | 0.270 |
Why?
|
| Swimming | 2 | 2004 | 212 | 0.260 |
Why?
|
| Male | 128 | 2024 | 364154 | 0.260 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2005 | 451 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2024 | 10745 | 0.250 |
Why?
|
| Thyrotropin | 9 | 1993 | 834 | 0.250 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2009 | 4628 | 0.240 |
Why?
|
| Depression | 6 | 2012 | 8225 | 0.240 |
Why?
|
| Allostasis | 1 | 2006 | 76 | 0.240 |
Why?
|
| Pituitary Hormones, Anterior | 5 | 1985 | 57 | 0.240 |
Why?
|
| Rats, Inbred Strains | 18 | 1991 | 2078 | 0.240 |
Why?
|
| Ganglionic Stimulants | 2 | 2003 | 18 | 0.240 |
Why?
|
| Serotonin Receptor Agonists | 2 | 1996 | 151 | 0.230 |
Why?
|
| Mexican Americans | 4 | 2012 | 165 | 0.230 |
Why?
|
| Dextrorphan | 1 | 2004 | 4 | 0.230 |
Why?
|
| Levorphanol | 1 | 2004 | 9 | 0.230 |
Why?
|
| Cues | 2 | 2006 | 877 | 0.230 |
Why?
|
| Adult | 88 | 2024 | 223305 | 0.230 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2005 | 286 | 0.230 |
Why?
|
| Iodophors | 1 | 2023 | 7 | 0.220 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2006 | 246 | 0.220 |
Why?
|
| Stress, Physiological | 9 | 2003 | 1407 | 0.220 |
Why?
|
| Hospitalization | 10 | 2024 | 10816 | 0.220 |
Why?
|
| Mothers | 2 | 2006 | 2208 | 0.220 |
Why?
|
| Mupirocin | 1 | 2023 | 55 | 0.220 |
Why?
|
| Baths | 1 | 2023 | 52 | 0.220 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2001 | 423 | 0.210 |
Why?
|
| Interpersonal Relations | 1 | 2011 | 1432 | 0.210 |
Why?
|
| Self Mutilation | 2 | 1995 | 57 | 0.210 |
Why?
|
| Dopamine Agonists | 1 | 2005 | 346 | 0.210 |
Why?
|
| Female | 97 | 2024 | 396532 | 0.210 |
Why?
|
| Polysomnography | 8 | 2013 | 1868 | 0.210 |
Why?
|
| Aspartic Acid | 3 | 2001 | 575 | 0.200 |
Why?
|
| Sleep Stages | 11 | 2013 | 705 | 0.200 |
Why?
|
| Pituitary Gland, Anterior | 4 | 1989 | 142 | 0.200 |
Why?
|
| Mental Processes | 1 | 2003 | 242 | 0.200 |
Why?
|
| Chlorhexidine | 1 | 2023 | 159 | 0.200 |
Why?
|
| Medical Order Entry Systems | 2 | 2024 | 523 | 0.200 |
Why?
|
| Analysis of Variance | 10 | 2006 | 6214 | 0.200 |
Why?
|
| Growth Hormone | 12 | 1991 | 572 | 0.190 |
Why?
|
| Catecholamines | 2 | 2002 | 388 | 0.190 |
Why?
|
| Sleep Deprivation | 3 | 2004 | 848 | 0.190 |
Why?
|
| Fludrocortisone | 1 | 2001 | 24 | 0.190 |
Why?
|
| Brain Chemistry | 5 | 1999 | 951 | 0.190 |
Why?
|
| Mineralocorticoids | 1 | 2001 | 37 | 0.180 |
Why?
|
| Humans | 132 | 2024 | 766812 | 0.180 |
Why?
|
| Ethanol | 7 | 2004 | 1326 | 0.180 |
Why?
|
| Serotonin | 4 | 2003 | 1045 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 4 | 2024 | 7475 | 0.180 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 1185 | 0.180 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 903 | 0.170 |
Why?
|
| Smoking | 3 | 2009 | 9077 | 0.170 |
Why?
|
| Buspirone | 1 | 2000 | 80 | 0.170 |
Why?
|
| Mydriatics | 1 | 1999 | 67 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 13 | 2004 | 6020 | 0.160 |
Why?
|
| Amitriptyline | 2 | 1991 | 110 | 0.160 |
Why?
|
| Middle Aged | 51 | 2024 | 223267 | 0.160 |
Why?
|
| Vital Signs | 1 | 2020 | 144 | 0.160 |
Why?
|
| Genotype | 3 | 2013 | 13036 | 0.160 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2023 | 705 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2005 | 956 | 0.160 |
Why?
|
| Catheter-Related Infections | 1 | 2022 | 279 | 0.160 |
Why?
|
| Dibenzocycloheptenes | 2 | 1989 | 27 | 0.160 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2023 | 627 | 0.160 |
Why?
|
| Buprenorphine | 2 | 2023 | 667 | 0.160 |
Why?
|
| Dizocilpine Maleate | 3 | 1995 | 171 | 0.150 |
Why?
|
| Arousal | 4 | 2010 | 1174 | 0.150 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 2 | 1996 | 32 | 0.150 |
Why?
|
| Substance-Related Disorders | 3 | 2009 | 4421 | 0.150 |
Why?
|
| Morpholines | 1 | 2001 | 584 | 0.150 |
Why?
|
| Hypotension, Orthostatic | 1 | 2001 | 258 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2001 | 3681 | 0.150 |
Why?
|
| Survivors | 2 | 2006 | 2379 | 0.150 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 453 | 0.140 |
Why?
|
| Myotonic Dystrophy | 1 | 1998 | 77 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2006 | 3226 | 0.140 |
Why?
|
| Fenfluramine | 1 | 1997 | 58 | 0.140 |
Why?
|
| Psychomotor Performance | 2 | 2003 | 1885 | 0.140 |
Why?
|
| Carbapenems | 1 | 2018 | 125 | 0.140 |
Why?
|
| Trinucleotide Repeats | 1 | 1998 | 257 | 0.140 |
Why?
|
| Receptors, sigma | 3 | 1994 | 46 | 0.140 |
Why?
|
| Cytochrome P-450 CYP2D6 | 3 | 2001 | 108 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 427 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 389 | 0.130 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2021 | 463 | 0.130 |
Why?
|
| Hospitals, Community | 3 | 2024 | 363 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2004 | 2669 | 0.130 |
Why?
|
| Reaction Time | 4 | 2002 | 2085 | 0.130 |
Why?
|
| Hospitals | 7 | 2023 | 3885 | 0.130 |
Why?
|
| Adolescent | 23 | 2021 | 88902 | 0.130 |
Why?
|
| Metalloporphyrins | 1 | 2016 | 41 | 0.130 |
Why?
|
| Receptors, Cholinergic | 1 | 1997 | 243 | 0.130 |
Why?
|
| Hyperbilirubinemia, Neonatal | 1 | 2016 | 30 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2023 | 987 | 0.130 |
Why?
|
| Naloxone | 3 | 1989 | 372 | 0.130 |
Why?
|
| Animals | 54 | 2008 | 168939 | 0.130 |
Why?
|
| United States Food and Drug Administration | 2 | 2021 | 1673 | 0.130 |
Why?
|
| Awards and Prizes | 1 | 2020 | 365 | 0.130 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2016 | 165 | 0.120 |
Why?
|
| Testosterone | 10 | 2003 | 2495 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2000 | 1143 | 0.120 |
Why?
|
| Brain | 14 | 2004 | 27158 | 0.120 |
Why?
|
| Endocrine Glands | 2 | 1987 | 101 | 0.120 |
Why?
|
| Pemoline | 1 | 1995 | 18 | 0.120 |
Why?
|
| Phenelzine | 1 | 1995 | 28 | 0.120 |
Why?
|
| United States | 20 | 2024 | 72945 | 0.120 |
Why?
|
| Bacteremia | 1 | 2022 | 987 | 0.120 |
Why?
|
| Receptors, Neurotransmitter | 4 | 1990 | 171 | 0.120 |
Why?
|
| Cross-Over Studies | 5 | 2013 | 2105 | 0.120 |
Why?
|
| Imipramine | 2 | 2000 | 96 | 0.120 |
Why?
|
| Anti-Anxiety Agents | 2 | 1997 | 404 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2023 | 1396 | 0.120 |
Why?
|
| Disease Outbreaks | 1 | 2024 | 1761 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2006 | 1805 | 0.110 |
Why?
|
| Norepinephrine | 4 | 2006 | 898 | 0.110 |
Why?
|
| Bilirubin | 1 | 2016 | 440 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2021 | 1308 | 0.110 |
Why?
|
| Medicare | 2 | 2023 | 6813 | 0.110 |
Why?
|
| Luteinizing Hormone | 11 | 1989 | 828 | 0.110 |
Why?
|
| Conditioning, Operant | 2 | 2006 | 306 | 0.110 |
Why?
|
| Age Factors | 10 | 2020 | 18397 | 0.110 |
Why?
|
| Epinephrine | 3 | 2006 | 782 | 0.110 |
Why?
|
| Sexual Maturation | 1 | 1995 | 256 | 0.110 |
Why?
|
| Therapeutic Touch | 1 | 2012 | 9 | 0.110 |
Why?
|
| Electronic Health Records | 5 | 2024 | 4880 | 0.100 |
Why?
|
| Proton Pump Inhibitors | 1 | 2018 | 550 | 0.100 |
Why?
|
| Extinction, Psychological | 2 | 2006 | 367 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2021 | 1389 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2161 | 0.100 |
Why?
|
| Hippocampus | 3 | 2003 | 3776 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 1999 | 1408 | 0.100 |
Why?
|
| Piperazines | 2 | 1995 | 2547 | 0.100 |
Why?
|
| Double-Blind Method | 8 | 2013 | 12430 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 1241 | 0.100 |
Why?
|
| Self Administration | 4 | 2006 | 386 | 0.100 |
Why?
|
| Aged | 29 | 2024 | 171344 | 0.100 |
Why?
|
| Postpartum Period | 1 | 1999 | 1195 | 0.100 |
Why?
|
| Cross-Cultural Comparison | 4 | 2012 | 636 | 0.090 |
Why?
|
| Nialamide | 1 | 1991 | 5 | 0.090 |
Why?
|
| Morphine | 5 | 1986 | 658 | 0.090 |
Why?
|
| Suicide, Attempted | 1 | 2020 | 1413 | 0.090 |
Why?
|
| Clostridium Infections | 1 | 2018 | 563 | 0.090 |
Why?
|
| 3,4-Methylenedioxyamphetamine | 1 | 1990 | 2 | 0.090 |
Why?
|
| Benzodiazepines | 2 | 1997 | 1137 | 0.090 |
Why?
|
| Cocaine | 4 | 2005 | 944 | 0.090 |
Why?
|
| Gene Frequency | 4 | 2013 | 3624 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 7119 | 0.090 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1990 | 85 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 2 | 2000 | 2671 | 0.090 |
Why?
|
| Injections, Subcutaneous | 5 | 1994 | 684 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2021 | 1543 | 0.090 |
Why?
|
| Serotonin Antagonists | 1 | 1990 | 146 | 0.090 |
Why?
|
| Hospital Mortality | 5 | 2022 | 5344 | 0.090 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1990 | 87 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2024 | 59548 | 0.080 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2024 | 592 | 0.080 |
Why?
|
| Inositol | 3 | 1999 | 215 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1804 | 0.080 |
Why?
|
| Mental Disorders | 4 | 1999 | 6869 | 0.080 |
Why?
|
| Somatoform Disorders | 1 | 2012 | 425 | 0.080 |
Why?
|
| Phencyclidine Abuse | 1 | 1988 | 8 | 0.080 |
Why?
|
| Electromyography | 3 | 2004 | 1398 | 0.080 |
Why?
|
| Pregnancy | 20 | 2006 | 30236 | 0.080 |
Why?
|
| Choline | 3 | 1999 | 511 | 0.080 |
Why?
|
| Saccharin | 2 | 1987 | 20 | 0.070 |
Why?
|
| Alprazolam | 1 | 1988 | 103 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 2188 | 0.070 |
Why?
|
| Drug Interactions | 5 | 2000 | 1419 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2006 | 81 | 0.070 |
Why?
|
| Risk Factors | 9 | 2021 | 74889 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3250 | 0.070 |
Why?
|
| Retrospective Studies | 11 | 2023 | 81657 | 0.070 |
Why?
|
| Codeine | 1 | 1987 | 52 | 0.070 |
Why?
|
| Drug Administration Schedule | 3 | 2011 | 4853 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2021 | 6422 | 0.070 |
Why?
|
| Receptors, Phencyclidine | 4 | 1990 | 13 | 0.070 |
Why?
|
| Receptors, Nicotinic | 2 | 2003 | 494 | 0.070 |
Why?
|
| Inpatients | 3 | 2024 | 2566 | 0.070 |
Why?
|
| Psychology | 1 | 2008 | 353 | 0.070 |
Why?
|
| Prisoners | 1 | 1990 | 315 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2016 | 2120 | 0.070 |
Why?
|
| Placebos | 2 | 2005 | 1659 | 0.060 |
Why?
|
| Morphinans | 1 | 1985 | 27 | 0.060 |
Why?
|
| Reference Values | 5 | 1999 | 4914 | 0.060 |
Why?
|
| Mental Health | 1 | 2020 | 3269 | 0.060 |
Why?
|
| Lithium | 2 | 1988 | 599 | 0.060 |
Why?
|
| Schizophrenic Psychology | 2 | 1992 | 1647 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2006 | 362 | 0.060 |
Why?
|
| Phenazocine | 3 | 1994 | 7 | 0.060 |
Why?
|
| Neoplasms | 2 | 2006 | 22350 | 0.060 |
Why?
|
| Azocines | 1 | 1985 | 20 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2000 | 4854 | 0.060 |
Why?
|
| Dehydroepiandrosterone | 1 | 2006 | 249 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 1986 | 2677 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 15912 | 0.060 |
Why?
|
| Minority Groups | 1 | 2012 | 1208 | 0.060 |
Why?
|
| Family Health | 1 | 2009 | 1254 | 0.060 |
Why?
|
| Schizophrenia | 5 | 1992 | 6976 | 0.060 |
Why?
|
| Disease Models, Animal | 6 | 2005 | 18329 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 1141 | 0.060 |
Why?
|
| Food Preferences | 2 | 1987 | 397 | 0.060 |
Why?
|
| ROC Curve | 2 | 1990 | 3621 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2010 | 9358 | 0.060 |
Why?
|
| Recurrence | 3 | 2010 | 8507 | 0.060 |
Why?
|
| Narcotic Antagonists | 2 | 1989 | 591 | 0.060 |
Why?
|
| Association Learning | 1 | 2005 | 219 | 0.060 |
Why?
|
| Aging | 3 | 1999 | 8728 | 0.060 |
Why?
|
| Antipsychotic Agents | 3 | 1995 | 3078 | 0.050 |
Why?
|
| Demography | 1 | 2008 | 1641 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2006 | 4249 | 0.050 |
Why?
|
| Adjustment Disorders | 1 | 1983 | 68 | 0.050 |
Why?
|
| Exploratory Behavior | 1 | 2004 | 271 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 5888 | 0.050 |
Why?
|
| Surgical Wound Infection | 2 | 2023 | 1547 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2004 | 514 | 0.050 |
Why?
|
| Causality | 1 | 2009 | 1252 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2003 | 504 | 0.050 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2012 | 1399 | 0.050 |
Why?
|
| Maze Learning | 1 | 2004 | 479 | 0.050 |
Why?
|
| Pandemics | 4 | 2024 | 8734 | 0.050 |
Why?
|
| Time Factors | 7 | 2013 | 40149 | 0.050 |
Why?
|
| Azetidines | 1 | 2003 | 151 | 0.050 |
Why?
|
| Psychotropic Drugs | 5 | 1991 | 880 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 482 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 315 | 0.050 |
Why?
|
| Endotoxins | 1 | 2004 | 519 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2024 | 319 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2006 | 943 | 0.050 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2023 | 246 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2003 | 563 | 0.050 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2001 | 117 | 0.050 |
Why?
|
| Anxiety Disorders | 3 | 2009 | 2743 | 0.040 |
Why?
|
| Virginia | 1 | 2020 | 115 | 0.040 |
Why?
|
| Alcoholic Intoxication | 1 | 1982 | 171 | 0.040 |
Why?
|
| Oxygen | 2 | 2024 | 4252 | 0.040 |
Why?
|
| Nervous System | 1 | 1984 | 542 | 0.040 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2000 | 61 | 0.040 |
Why?
|
| Military Personnel | 1 | 1990 | 1260 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2004 | 966 | 0.040 |
Why?
|
| Cyclohexanols | 1 | 2000 | 126 | 0.040 |
Why?
|
| Memory | 1 | 1990 | 2192 | 0.040 |
Why?
|
| Creatine | 2 | 1999 | 424 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2001 | 1639 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 708 | 0.040 |
Why?
|
| Azithromycin | 1 | 2021 | 201 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 1989 | 1921 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2023 | 3799 | 0.040 |
Why?
|
| California | 2 | 2001 | 1435 | 0.040 |
Why?
|
| Biological Assay | 2 | 1994 | 626 | 0.040 |
Why?
|
| Glucocorticoids | 2 | 2024 | 2158 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 1980 | 182 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3429 | 0.040 |
Why?
|
| Antiviral Agents | 2 | 2021 | 3070 | 0.040 |
Why?
|
| Child | 8 | 2023 | 80670 | 0.040 |
Why?
|
| Adrenal Glands | 3 | 1989 | 556 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2004 | 429 | 0.040 |
Why?
|
| Intelligence | 1 | 2003 | 925 | 0.040 |
Why?
|
| Disease Progression | 2 | 2021 | 13642 | 0.040 |
Why?
|
| Opiate Substitution Treatment | 1 | 2023 | 452 | 0.040 |
Why?
|
| Hormones | 3 | 1996 | 866 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 1998 | 41 | 0.040 |
Why?
|
| Alkaloids | 1 | 1999 | 192 | 0.040 |
Why?
|
| Cholesterol | 2 | 2006 | 2904 | 0.040 |
Why?
|
| Sample Size | 1 | 2001 | 844 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2021 | 9661 | 0.040 |
Why?
|
| Narcotics | 1 | 2000 | 332 | 0.040 |
Why?
|
| Motor Activity | 2 | 2006 | 2711 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2000 | 4019 | 0.040 |
Why?
|
| Computers | 1 | 2020 | 589 | 0.040 |
Why?
|
| Sex Factors | 6 | 2004 | 10619 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1998 | 113 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 5 | 1989 | 731 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1998 | 146 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1996 | 94 | 0.030 |
Why?
|
| Observation | 1 | 1999 | 310 | 0.030 |
Why?
|
| Wakefulness | 1 | 2004 | 1282 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2009 | 39312 | 0.030 |
Why?
|
| Binding Sites | 1 | 2005 | 6013 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1998 | 766 | 0.030 |
Why?
|
| Infection Control | 1 | 2024 | 984 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2021 | 8728 | 0.030 |
Why?
|
| Secretory Rate | 2 | 1986 | 82 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2001 | 36570 | 0.030 |
Why?
|
| Creatinine | 2 | 2001 | 1917 | 0.030 |
Why?
|
| Panic | 2 | 1985 | 103 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2001 | 1194 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2003 | 22248 | 0.030 |
Why?
|
| Motivation | 1 | 2005 | 2020 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2023 | 1429 | 0.030 |
Why?
|
| Cyclazocine | 2 | 1985 | 10 | 0.030 |
Why?
|
| Ethylketocyclazocine | 2 | 1985 | 4 | 0.030 |
Why?
|
| Protons | 2 | 1998 | 1101 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2012 | 65286 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2021 | 8065 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1990 | 1142 | 0.030 |
Why?
|
| Young Adult | 5 | 2021 | 59939 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 935 | 0.030 |
Why?
|
| Dioxolanes | 1 | 1994 | 23 | 0.030 |
Why?
|
| Sympathomimetics | 1 | 1994 | 56 | 0.030 |
Why?
|
| Cortisone | 1 | 1995 | 90 | 0.030 |
Why?
|
| Length of Stay | 2 | 2024 | 6491 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 857 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1994 | 186 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2010 | 14762 | 0.030 |
Why?
|
| Comorbidity | 1 | 2009 | 10580 | 0.030 |
Why?
|
| Language | 1 | 2003 | 1550 | 0.030 |
Why?
|
| Alcohol Drinking | 2 | 2004 | 4045 | 0.030 |
Why?
|
| Bites and Stings | 1 | 1995 | 94 | 0.030 |
Why?
|
| Alleles | 3 | 2001 | 6896 | 0.030 |
Why?
|
| Benzodiazepinones | 1 | 1973 | 50 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1994 | 612 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 1377 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1622 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1688 | 0.030 |
Why?
|
| Patient Admission | 1 | 2020 | 1364 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15425 | 0.030 |
Why?
|
| Vanilmandelic Acid | 1 | 1972 | 17 | 0.030 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1972 | 38 | 0.030 |
Why?
|
| Phototherapy | 1 | 2016 | 368 | 0.030 |
Why?
|
| Colon | 1 | 2021 | 1797 | 0.030 |
Why?
|
| Pregnancy Complications | 3 | 1999 | 2971 | 0.030 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1991 | 16 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1997 | 1003 | 0.020 |
Why?
|
| Aggression | 1 | 1996 | 748 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2006 | 8533 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1996 | 1757 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 1996 | 682 | 0.020 |
Why?
|
| Pyridines | 1 | 2003 | 2888 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36459 | 0.020 |
Why?
|
| Institutionalization | 1 | 1991 | 108 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2016 | 619 | 0.020 |
Why?
|
| Compulsive Behavior | 1 | 1991 | 117 | 0.020 |
Why?
|
| Thyroxine | 2 | 1987 | 665 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 42577 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1991 | 411 | 0.020 |
Why?
|
| Personality Tests | 1 | 1990 | 80 | 0.020 |
Why?
|
| MMPI | 1 | 1990 | 80 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2000 | 2703 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 1467 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3466 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2023 | 41706 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 1985 | 3275 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2727 | 0.020 |
Why?
|
| Organ Size | 2 | 1987 | 2262 | 0.020 |
Why?
|
| Psychopharmacology | 1 | 1991 | 146 | 0.020 |
Why?
|
| Scotland | 1 | 1989 | 142 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1998 | 1552 | 0.020 |
Why?
|
| Protein Binding | 1 | 2001 | 9326 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1989 | 227 | 0.020 |
Why?
|
| Health Policy | 1 | 2021 | 2697 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14473 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 1989 | 156 | 0.020 |
Why?
|
| Body Weight | 5 | 1996 | 4626 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1996 | 1345 | 0.020 |
Why?
|
| Stimulation, Chemical | 2 | 1986 | 305 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 1990 | 241 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2006 | 13050 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1995 | 1312 | 0.020 |
Why?
|
| Pineal Gland | 1 | 1989 | 158 | 0.020 |
Why?
|
| Electroshock | 2 | 1986 | 120 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15652 | 0.020 |
Why?
|
| Analgesics | 1 | 1994 | 1068 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2010 | 54872 | 0.020 |
Why?
|
| Indians, North American | 1 | 1991 | 354 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12826 | 0.020 |
Why?
|
| Alcoholism | 1 | 1998 | 1980 | 0.020 |
Why?
|
| Iran | 1 | 1990 | 762 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3837 | 0.020 |
Why?
|
| Piperidines | 1 | 1994 | 1663 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1987 | 655 | 0.020 |
Why?
|
| Los Angeles | 1 | 2006 | 244 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2003 | 1529 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13276 | 0.020 |
Why?
|
| Reinforcement Schedule | 1 | 2005 | 123 | 0.020 |
Why?
|
| Heart Rate | 2 | 2013 | 4207 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22351 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1973 | 1193 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1987 | 493 | 0.020 |
Why?
|
| Clonidine | 1 | 1986 | 170 | 0.020 |
Why?
|
| Endorphins | 2 | 1986 | 73 | 0.010 |
Why?
|
| Vasopressins | 2 | 1978 | 358 | 0.010 |
Why?
|
| Thyroid Gland | 2 | 1989 | 1170 | 0.010 |
Why?
|
| Disorders of Sex Development | 1 | 1986 | 129 | 0.010 |
Why?
|
| Prevalence | 1 | 2022 | 15835 | 0.010 |
Why?
|
| Incidence | 1 | 2023 | 21527 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9244 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5367 | 0.010 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1986 | 193 | 0.010 |
Why?
|
| Propranolol | 1 | 1986 | 493 | 0.010 |
Why?
|
| Melatonin | 1 | 1989 | 670 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2003 | 144 | 0.010 |
Why?
|
| Microdialysis | 1 | 2003 | 156 | 0.010 |
Why?
|
| Antitussive Agents | 1 | 2001 | 19 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1981 | 150 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6306 | 0.010 |
Why?
|
| Bipolar Disorder | 3 | 1990 | 5130 | 0.010 |
Why?
|
| Sex Characteristics | 2 | 1995 | 2645 | 0.010 |
Why?
|
| Submandibular Gland | 1 | 1981 | 85 | 0.010 |
Why?
|
| Estradiol | 1 | 1989 | 1947 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9602 | 0.010 |
Why?
|
| Hypothermia | 1 | 1983 | 189 | 0.010 |
Why?
|
| Mice | 3 | 2006 | 81898 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1997 | 5753 | 0.010 |
Why?
|
| Phenotype | 3 | 2006 | 16722 | 0.010 |
Why?
|
| Family | 1 | 1991 | 3209 | 0.010 |
Why?
|
| Heart | 1 | 2013 | 4425 | 0.010 |
Why?
|
| Gene Duplication | 1 | 2001 | 315 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2013 | 6408 | 0.010 |
Why?
|
| Eating | 1 | 1987 | 1539 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 14073 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2001 | 2168 | 0.010 |
Why?
|
| Ion Exchange Resins | 1 | 1978 | 8 | 0.010 |
Why?
|
| Analgesia | 1 | 1984 | 461 | 0.010 |
Why?
|
| Anion Exchange Resins | 1 | 1978 | 10 | 0.010 |
Why?
|
| Trichloroacetic Acid | 1 | 1978 | 48 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26309 | 0.010 |
Why?
|
| China | 1 | 1985 | 2386 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1981 | 697 | 0.010 |
Why?
|
| Talc | 1 | 1978 | 48 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1981 | 564 | 0.010 |
Why?
|
| Asia | 2 | 1991 | 629 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1988 | 6329 | 0.010 |
Why?
|
| Half-Life | 1 | 1999 | 648 | 0.010 |
Why?
|
| Peptides | 2 | 1981 | 4347 | 0.010 |
Why?
|
| Pituitary Gland | 2 | 1987 | 635 | 0.010 |
Why?
|
| Methadone | 1 | 1980 | 317 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1998 | 455 | 0.010 |
Why?
|
| Social Dominance | 1 | 1996 | 39 | 0.010 |
Why?
|
| Anxiety | 1 | 2012 | 4668 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1978 | 326 | 0.010 |
Why?
|
| Fear | 1 | 1985 | 1496 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1999 | 418 | 0.010 |
Why?
|
| Psychological Tests | 2 | 1989 | 642 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 3274 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26387 | 0.010 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1975 | 70 | 0.010 |
Why?
|
| Telemetry | 1 | 1996 | 201 | 0.010 |
Why?
|
| Rabbits | 1 | 1981 | 4752 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 2228 | 0.010 |
Why?
|
| Body Water | 1 | 1996 | 337 | 0.010 |
Why?
|
| Kidney | 1 | 1990 | 7073 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1989 | 3283 | 0.010 |
Why?
|
| Flurazepam | 1 | 1973 | 8 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 6613 | 0.010 |
Why?
|
| Diffusion | 1 | 1995 | 808 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1988 | 5092 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 7585 | 0.010 |
Why?
|
| Aldosterone | 1 | 1978 | 881 | 0.010 |
Why?
|
| Glutamine | 1 | 1996 | 575 | 0.010 |
Why?
|
| Body Temperature | 1 | 1996 | 780 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1990 | 12985 | 0.010 |
Why?
|
| Glycols | 1 | 1970 | 54 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 12795 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1996 | 1181 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1996 | 2341 | 0.010 |
Why?
|
| Aerospace Medicine | 1 | 1970 | 95 | 0.010 |
Why?
|
| Periodicity | 1 | 1991 | 347 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1976 | 2350 | 0.010 |
Why?
|
| Basal Ganglia Diseases | 1 | 1989 | 145 | 0.000 |
Why?
|
| Emigration and Immigration | 1 | 1991 | 405 | 0.000 |
Why?
|
| DNA | 1 | 2001 | 7210 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1989 | 365 | 0.000 |
Why?
|
| Professional-Family Relations | 1 | 1991 | 500 | 0.000 |
Why?
|
| Suicide | 1 | 1997 | 1606 | 0.000 |
Why?
|
| Kinetics | 2 | 1986 | 6288 | 0.000 |
Why?
|
| Thyroid Hormones | 1 | 1989 | 408 | 0.000 |
Why?
|
| Agoraphobia | 1 | 1985 | 177 | 0.000 |
Why?
|
| Uric Acid | 1 | 1971 | 809 | 0.000 |
Why?
|
| Personality Inventory | 1 | 1987 | 1019 | 0.000 |
Why?
|
| Sodium | 2 | 1978 | 1594 | 0.000 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1980 | 56 | 0.000 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1175 | 0.000 |
Why?
|
| Caregivers | 1 | 1991 | 2303 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1978 | 174 | 0.000 |
Why?
|
| Adsorption | 1 | 1978 | 198 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1978 | 390 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1987 | 2779 | 0.000 |
Why?
|
| Learning | 1 | 1986 | 1754 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1972 | 8045 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1998 | 18076 | 0.000 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1980 | 1331 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1978 | 1030 | 0.000 |
Why?
|
| Naval Medicine | 1 | 1971 | 30 | 0.000 |
Why?
|
| Diving | 1 | 1971 | 43 | 0.000 |
Why?
|
| Pain | 1 | 1986 | 5098 | 0.000 |
Why?
|
| Sampling Studies | 1 | 1971 | 614 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1990 | 20710 | 0.000 |
Why?
|